Andropause vs. menopause: same word energy, different biology

What did @docteurscharles.co actually say?

Honestly, the transcript here is nearly unintelligible. The audio-to-text capture produced garbled output referencing "a clinic that corresponds to the deficit and testosterone" and something about a "drug sexual" that is "non-sexual." The video's caption is clearer: @docteurscharles.co argues that andropause is not simply "the male menopause." That framing, at least, is a legitimate clinical distinction worth examining.

Because we cannot responsibly quote specifics from a corrupted transcript, this fact-check focuses on the core claim embedded in the caption and category context: that andropause and menopause are fundamentally different phenomena, and that testosterone deficiency in men should be understood on its own clinical terms. If that is indeed what the creator argued, they are largely correct, and it is a correction the internet badly needs.

Does the science back this up?

Yes, substantially. Menopause is a universal, abrupt, and complete cessation of ovarian hormone production. Andropause, or late-onset hypogonadism, is none of those things, and conflating the two misleads patients about what to expect and when to seek help.

A landmark paper by Wu et al. (2010, New England Journal of Medicine) established that late-onset hypogonadism is defined by a serum total testosterone below 11 nmol/L combined with at least three sexual symptoms. Crucially, testosterone decline in men is gradual, roughly 1-2% per year after age 30, according to Harman et al. (2001, Journal of Clinical Endocrinology and Metabolism). There is no single "off switch." The European Male Ageing Study confirmed that only about 2.1% of men aged 40-79 actually meet diagnostic criteria for late-onset hypogonadism at any given time, far fewer than the broad "male menopause" framing implies.

What did they get wrong (or right)?

Based on the caption alone, the creator appears to be pushing back against a genuine misconception, and that is worth crediting. The "male menopause" label is not just imprecise, it is clinically harmful because it can lead men to assume testosterone loss is as inevitable and total as ovarian shutdown, which it is not. It can also lead clinicians and patients to dismiss symptoms that are actually treatable.

Where creators in this space routinely go wrong, and where we cannot confirm @docteurscharles.co avoided this trap given the corrupted transcript, is overstating what TRT fixes. The Testosterone Trials (Snyder et al., 2016, New England Journal of Medicine) showed modest improvements in sexual function and some benefit to bone density, but mixed results for energy and mood. TRT is not a universal anti-aging solution. If the creator implied otherwise, that would be misleading regardless of how correct the andropause-vs-menopause framing is.

What should you actually know?

Late-onset hypogonadism is a real, diagnosable condition, but it requires confirmed low serum testosterone on at least two morning measurements plus specific symptoms. The Endocrine Society guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) are explicit: do not treat a number alone, and do not treat aging itself.

The "male menopause" shorthand is popular because it is relatable, but it sets wrong expectations. Men considering TRT evaluation should know a few things clearly:

• Symptoms like fatigue, low libido, and mood changes overlap with dozens of other conditions, including thyroid dysfunction, depression, and sleep apnea. These must be ruled out first.
• TRT carries real risks including erythrocytosis, cardiovascular considerations, and suppression of natural testosterone production and fertility.
• A social media video, however well-intentioned, is not a substitute for a proper hormone panel and clinical evaluation.

If you are watching TikTok videos about TRT and wondering whether your symptoms fit, that curiosity is valid. Acting on a caption without a blood test is not.